https://www.marketscreener.com/quote/stock/TURG-POIN-57237713/news/Turning-Point-Therapeutics-Announces-Early-Clinical-Data-for-Repotrectinib-in-NTRK-Fusion-Positive-36377893/?utm_source=telegram&utm_medium=social&utm_campaign=share